Early warning of long-term hospitalization in schizophrenia (SCZ) patients at the time of admission is crucial for effective resource allocation and individual treatment planning. In this study, we developed a deep learning model that integrates demographic, behavioral, and blood test data from admission to forecast extended hospital stays using a retrospective cohort. By utilizing language models, our developed algorithm efficiently extracts 95% of the unstructured electronic health records data needed for this work, while ensuring data privacy and low error rate. This paradigm has also been demonstrated to have significant advantages in reducing potential discrimination and erroneous dependencies. By utilizing multimodal features, our deep learning model achieved a classification accuracy of 0.81 and an AUC of 0.9. Key risk factors identified included advanced age, longer disease duration, and blood markers such as elevated neutrophil-to-lymphocyte ratio, lower lymphocyte percentage, and reduced albumin levels, validated through comprehensive interpretability analyses and ablation studies. The inclusion of multimodal data significantly improved prediction performance, with demographic variables alone achieving an accuracy of 0.73, which increased to 0.81 with the addition of behavioral and blood test data. Our approach outperformed traditional machine learning methods, which were less effective in predicting long-term stays. This study demonstrates the potential of integrating diverse data types for enhanced predictive accuracy in mental health care, providing a robust framework for early intervention and personalized treatment in SCZ management.

Predicting the pathogenic consequences of protein mutations is a cornerstone of precision medicine, yet it remains a formidable challenge for transmembrane proteins (TMPs), a clinically vital class of drug targets. Existing computational methods are often hampered by their reliance on evolutionary data and fail to model TMP-specific biophysical constraints. Here, we introduce Memo-Patho, a deep learning framework for robust, alignment-free pathogenicity prediction of TMP variants. The core innovation is a within-protein, label-informed supervised contrastive pretraining strategy that learns sequence-encoded biophysical signatures distinguishing pathogenic and benign variants by directly comparing them within the same protein context. By fusing sequence-level representations from protein language models with local structural proxies derived from sequence, Memo-Patho achieves accurate predictions without multiple sequence alignments or experimental structures. Across diverse TMP benchmarks and under protein-level group splits, Memo-Patho consistently outperforms leading predictors, achieving up to 0.93 accuracy, and it transfers to an independent KCNQ1 ion-channel cohort without re-training. Its resource-efficient, alignment-free design enables routine large-scale screening when evolutionary or structural data are sparse. Conceptually, Memo-Patho addresses a key gap by directly learning discriminative, sequence-anchored signatures pertinent to TMP-specific constraints, offering a principled and generalizable foundation for research-use clinical variant triage and proteome-wide mutation-effect modeling.

Transmembrane proteins (TMPs) serve as drug targets for more than half of the drugs currently available in the market. However, it had not been clearly explained how they realize their drug effects through multiple complex molecules bindings actions. Research into TMPs bindings and corresponding structural basis will provide key information for drug research and new drug development. In this study, we defined the binding domain of TMPs according to the binding region investigation of multiple conjugate types. A 3D deep learning model was architected to discover the structural universality inside those domains. The experimental results proved such binding domains existing on the surface of TMPs, and they are structural specific distinguishing to the surface regions without any binding activities. This work provides a new theoretical basis for TMPs binding research and can greatly boost the development of the drug industry.